Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Appl Microbiol ; 130(3): 786-796, 2021 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-32615006

RESUMO

AIMS: The emergence of multidrug resistant strains of Mycobacterium tuberculosis has made tuberculosis more difficult to manage clinically. With the aim of obtaining new and effective anti-mycobacterial agent(s), this study investigated the anti-mycobacterial activity of several imidazole and piperidine derivatives. METHODS AND RESULTS: Towards obtaining new anti-mycobacterial agents, Mycobacterium smegmatis cells were treated with different compounds for their growth inhibitory activity. Among these, benzyl 1H-imidazole-1-carbodithioate and allyl piperidine-1-carbodiothioate exhibited better inhibition than the others. Thereafter, anti-biofilm property of these two was examined by treating M. smegmatis with these agents before and after the formation of biofilm. The result showed that both the compounds at their sublethal dose inhibited the formation of biofilm as well as dispersed preformed biofilm. Consistently, they augmented the activity of isoniazid or rifampicin against biofilm-encapsulated cells. MTT assay was performed to examine the toxic effects of this combinatorial therapy on different cell lines. Results exhibited a low cytotoxicity for this combinatorial treatment. The activity of these two was also verified against dormant mycobacterial cells and was found to be effective. CONCLUSION: The present study identified two compounds that exhibited anti-mycobacterial activities against both planktonic and dormant cells. These two also exhibited anti-biofilm activity at their sublethal dose and augmented the activity of isoniazid and rifampicin against biofilm encapsulated cells. SIGNIFICANCE AND IMPACT OF THE STUDY: The current study provides two new agents that have the potential to be used in anti-mycobacterial therapy and may help in public health management.


Assuntos
Antibacterianos/farmacologia , Imidazóis/farmacologia , Mycobacterium smegmatis/efeitos dos fármacos , Piperidinas/farmacologia , Biofilmes/efeitos dos fármacos , Biofilmes/crescimento & desenvolvimento , Humanos , Testes de Sensibilidade Microbiana , Rifampina/farmacologia
2.
Spectrochim Acta A Mol Biomol Spectrosc ; 131: 413-23, 2014 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-24835945

RESUMO

In this article, a cleaner, greener, cheaper and environment friendly method for the generation of self assembled silver nanoparticles (Ag NPs) applying a simple irradiation technique using the aqueous extract of the fish scales (which is considered as a waste material) of Labeo rohita is described. Gelatin is considered as the major ingredient responsible for the reduction as well as stabilisation of the self assembled Ag NPs. The size and morphology of the individual Ag NPs can be tuned by controlling the various reaction parameters, such as temperature, concentration, and pH. Studies showed that on increasing concentration and pH Ag NPs size decreases, while on increasing temperature, Ag NPs size increases. The present process does not need any external reducing agent, like sodium borohydride or hydrazine or others and gelatin itself can play a dual role: a 'reducing agent' and 'stabilisation agent' for the formation of gelatin-Ag NPs colloidal dispersion. The synthesized Ag NPs were characterised by Ultraviolet-Visible spectroscopy (UV-Vis), Transmission electron microscopy (TEM) and Selected area electron diffraction (SAED) analyses. The synthesized Ag NPs was used to study the catalytic reduction of various aromatic nitro compounds in aqueous and three different micellar media. The hydrophobic and electrostatic interaction between the micelle and the substrate is responsible for the catalytic activity of the nanoparticles in micelle.


Assuntos
Gelatina/química , Química Verde/métodos , Nanopartículas Metálicas/química , Nitrocompostos/química , Substâncias Redutoras/química , Prata/química , Animais , Biomimética/métodos , Catálise , Cyprinidae/anatomia & histologia , Hidrocarbonetos Aromáticos/química , Nanopartículas Metálicas/ultraestrutura , Oxirredução
3.
J Appl Microbiol ; 116(2): 295-303, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24165295

RESUMO

AIM: Polyethylene succinate (PES) contains hydrolysable ester bonds that make it a potential substitute for polyethylene (PE) and polypropylene (PP). Towards bioremediation of PES, we have already reported that a new strain of Pseudomonas, Pseudomonas sp. AKS2, can efficiently degrade PES and hypothesized that cell surface hydrophobicity plays an important role in this degradation process. In this study, our efforts were targeted towards establishing a correlation between cell surface hydrophobicity and PES degradation. METHODS AND RESULTS: We have manipulated cell surface hydrophobicity of AKS2 by varying concentrations of glucose and ammonium sulphate in the growth medium and subsequently examined the extent of PES degradation. We observed an increase in PES degradation by AKS2 with an increase in cell surface hydrophobicity. The increased surface hydrophobicity caused an enhanced biofilm formation on PES surface that resulted in better polymer degradation. CONCLUSION: The current study establishes a direct correlation between cell surface hydrophobicity of an organism and its potential to degrade a nonpolar polymer like PES. SIGNIFICANCE AND IMPACT OF THE STUDY: Cell surface hydrophobicity manipulation can be used as an important strategy to increase bioremediation of nonpolar polymer like PES.


Assuntos
Polietilenos/metabolismo , Pseudomonas/metabolismo , Succinatos/metabolismo , Sulfato de Amônio/metabolismo , Aderência Bacteriana , Biodegradação Ambiental , Biofilmes/crescimento & desenvolvimento , Membrana Celular/metabolismo , Meios de Cultura/química , Glucose/metabolismo , Interações Hidrofóbicas e Hidrofílicas , Polissacarídeos Bacterianos/isolamento & purificação , Poliestirenos/metabolismo , Pseudomonas/fisiologia
4.
Oncogenesis ; 1: e8, 2012 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-23552605

RESUMO

Cigarette smoke (CS), a major risk factor for developing lung cancer, is known to activate transcriptional activator nuclear factor kappa B (NF-κB). However, the underlying mechanism of this activation remains unclear because of conflicting reports. As NF-κB has a pivotal role in the generation and maintenance of malignancies, efforts were targeted towards understanding its activation mechanism using both ex vivo and in vivo studies. The results show that CS-induced NF-κB activation mechanism is different from that of other pro-inflammatory signals such as lipopolysaccharide (LPS). The NF-κB dimer that translocates to the nucleus upon stimulation with CS is predominantly composed of c-Rel/p50 and this translocation involves degradation of I-κBɛ and not I-κBα. This degradation of I-κBɛ depends on IKKß activity, which preferentially targets I-κBɛ. Consistently, CS-activated form of IKKß was found to be different from that involved in LPS activation as neither Ser177 nor Ser181 of IKKß is crucial for CS-induced NF-κB activation. Thus, unlike other pro-inflammatory stimulations where p65 and I-κBα have a central role, the predominantly active signaling cascade in CS-induced NF-κB activation in the lung epithelial cells comprises of IKKß-I-κBɛ-c-Rel/p50. Thus, this study uncovers a new axis of NF-κB activation wherein I-κBɛ and c-Rel have the central role.

5.
Inflamm Res ; 58(1): 22-9, 2009 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-19115041

RESUMO

OBJECTIVE: Cigarette smoke is able to induce the generation of reactive oxygen species and pro-inflammatory cytokines, which are mediators of macrophage function and therefore, we have investigated the ability of cigarette smoke to activate Leishmania donovani infected peritoneal macrophage. MATERIALS AND METHODS: Cultured peritoneal macrophages were either left untreated or treated with aqueous cigarette smoke extract prior to L. donovani infection. Parasite burden was assessed by giemsa staining. The level of intracellular reactive oxygen species was determined by FACS analysis. PCR was performed to analyze mRNA levels of cytokines. NF- kappaB activity was assessed by EMSA and reporter assay. RESULTS: A pre-treatment with cigarette smoke extract (CSE) causes a decrease in parasite burden, an increase in intracellular ROS level, up-regulation of pro-inflammatory cytokines, reduced expression of immuno-suppressive cytokine and boosting of NF-kappaB activity in L. donovani-infected macrophage. CONCLUSION: Low concentration of cigarette smoke extract (CSE) counteracts L. donovani infection-mediated suppression of macrophage function without affecting host cell viability. This study reveals a new role of cigarette smoke extract (CSE) as an activator of macrophage function.


Assuntos
Leishmania donovani , Leishmaniose Visceral/imunologia , Macrófagos Peritoneais , Nicotiana/química , Fumaça , Animais , Citocinas/imunologia , Humanos , Leishmania donovani/imunologia , Leishmania donovani/patogenicidade , Macrófagos Peritoneais/efeitos dos fármacos , Macrófagos Peritoneais/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , NF-kappa B/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Fumar
6.
J Indian Med Assoc ; 99(10): 557-60, 2001 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-12018540

RESUMO

To date there are no published studies on blindness in children or on its incidence. Recently information on the causes of blindness in children identified by community based rehabilitation programmes in two states of India has provided very useful population based data. Prevalence and magnitude of blindness in children in India, avoidable causes and control of blindness in children at the primary, secondary and tertiary levels of health care are discussed in this article along with probable areas of research.


Assuntos
Cegueira/epidemiologia , Serviços de Saúde da Criança/organização & administração , Cegueira/etiologia , Cegueira/prevenção & controle , Cegueira/terapia , Criança , Humanos , Incidência , Índia/epidemiologia
7.
Ophthalmic Epidemiol ; 7(2): 127-38, 2000 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-10934463

RESUMO

BACKGROUND: The prevalence and causes of blindness in children vary widely between regions. Few epidemiological data are available on the relative importance of the major congenital anomalies of the globe (i.e., microphthalmos, anophthalmos, coloboma) as causes of blindness in children. The aim of this study was to determine the re-gional variation in the proportion of severe visual impairment and blindness due to congenital abnormalities of the globe in children in schools for the blind and in those identified through Community Based Rehabilitation programs. Other objectives were to estimate the prevalence of blindness due to major congenital abnormalities, and to investigate their etiology. METHODS: Data on the causes of blindness in children were collected between 1990 and 1998 using standard methods, definitions and reporting form in 26 countries. Children were examined in schools for the blind and in Community Based Rehabilitation programs. RESULTS: Of 7,113 children aged 3-15 years with severe visual impairment and blindness examined, 762 (10.7%) had microphthalmos, 161 (2.3%) had anophthalmos, and 96 (1.3%) had coloboma. There are large regional differences in the proportion of severe visual loss in blind school children, ranging from 1.4% in Cuba to 33.2% in Sri Lanka. Severe visual loss due to congenital abnormalities of the globe is estimated to affect between 0.4 and 16.2/100,000 children in the countries studied. An underlying cause could not be identified in 84.2%. CONCLUSIONS: Major congenital abnormalities of the globe are important causes of severe visual loss in children, particularly in Asian countries. Further research into etiology is warranted in order to plan prevention programs.


Assuntos
Anoftalmia/complicações , Cegueira/epidemiologia , Coloboma/complicações , Microftalmia/complicações , Adolescente , Anoftalmia/epidemiologia , Cegueira/etiologia , Cegueira/reabilitação , Criança , Pré-Escolar , Coloboma/epidemiologia , Avaliação da Deficiência , Saúde Global , Humanos , Microftalmia/epidemiologia , Prevalência , Estudos Retrospectivos
8.
Protein Expr Purif ; 18(2): 202-12, 2000 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-10686151

RESUMO

The Gal4, Gal80, and Gal3 proteins of Saccharomyces cerevisiae constitute a galactose-responsive regulatory switch for GAL gene promoters. The low cellular levels of these proteins have hampered mechanistic studies and limit the utility of the GAL gene promoters for high-yield production of endogenous and exogenous proteins. We have constructed two new vectors, pMEGA2 and pMEGA2-DeltaURA3, that increase the level of the Gal4p-Gal80p-Gal3p switch proteins under conditions that preserve the Gal3p-Gal80p-Gal4p stoichiometries required for normal switch function. Cells carrying pMEGA2 show 15- to 20-fold more Gal4p and 30- to 40-fold more Gal3p and Gal80p than cells lacking pMEGA2. These high levels of Gal4p, Gal80p, and Gal3p do not perturb the integrity of galactose-inducible regulation. Cells that carry pMEGA2 exhibit normal galactose-induction kinetics for the chromosomal MEL1 gene expression and normal, albeit slower, log-phase growth. Insertion of the MEL1 gene into pMEGA2 provides a 24- to 30-fold increase in the Mel1 protein. Cells carrying a 2-microm-based URA3-selectable plasmid containing a GAL1pro:lacZ reporter gene and a second plasmid, pMEGA2-DeltaURA3, produce 12-fold more beta-galactosidase than cells carrying only the GAL1pro:lacZ reporter plasmid. The performance of the MEGA plasmids in providing amplified production of the Gal3, Gal80, and Gal4 proteins should prove useful in investigations of the mechanistic aspects of these transcription switch proteins and in work aimed at achieving high-level, galactose-regulatable production of proteins in yeast.


Assuntos
Proteínas Fúngicas/biossíntese , Galactose/genética , Vetores Genéticos , Proteínas Repressoras , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/genética , Fatores de Transcrição/biossíntese , DNA Recombinante/genética , Proteínas de Ligação a DNA , Indução Enzimática , Proteínas Fúngicas/genética , Galactose/biossíntese , Regulação da Expressão Gênica , Regiões Promotoras Genéticas , Saccharomyces cerevisiae/metabolismo , Fatores de Transcrição/genética , alfa-Galactosidase/biossíntese , beta-Galactosidase/biossíntese
9.
Community Eye Health ; 13(34): 32, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-17491955
10.
Mol Cell Biol ; 19(11): 7828-40, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10523671

RESUMO

The Gal3, Gal80, and Gal4 proteins of Saccharomyces cerevisiae comprise a signal transducer that governs the galactose-inducible Gal4p-mediated transcription activation of GAL regulon genes. In the absence of galactose, Gal80p binds to Gal4p and prohibits Gal4p from activating transcription, whereas in the presence of galactose, Gal3p binds to Gal80p and relieves its inhibition of Gal4p. We have found that immunoprecipitation of full-length Gal4p from yeast extracts coprecipitates less Gal80p in the presence than in the absence of Gal3p, galactose, and ATP. We have also found that retention of Gal80p by GSTG4AD (amino acids [aa] 768 to 881) is markedly reduced in the presence compared to the absence of Gal3p, galactose, and ATP. Consistent with these in vitro results, an in vivo two-hybrid genetic interaction between Gal80p and Gal4p (aa 768 to 881) was shown to be weaker in the presence than in the absence of Gal3p and galactose. These compiled results indicate that the binding of Gal3p to Gal80p results in destabilization of a Gal80p-Gal4p complex. The destabilization was markedly higher for complexes consisting of G4AD (aa 768 to 881) than for full-length Gal4p, suggesting that Gal80p relocated to a second site on full-length Gal4p. Congruent with the idea of a second site, we discovered a two-hybrid genetic interaction involving Gal80p and the region of Gal4p encompassing aa 225 to 797, a region of Gal4p linearly remote from the previously recognized Gal80p binding peptide within Gal4p aa 768 to 881.


Assuntos
Trifosfato de Adenosina/farmacologia , Galactose/farmacologia , Proteínas Repressoras , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/genética , Fatores de Transcrição/metabolismo , Ativação Transcricional/efeitos dos fármacos , Proteínas de Ligação a DNA , Escherichia coli/genética , Proteínas Fúngicas/metabolismo , Regulação Fúngica da Expressão Gênica , Genes Reporter , Óperon Lac , Substâncias Macromoleculares , Modelos Genéticos , Testes de Precipitina , Ligação Proteica/efeitos dos fármacos , Conformação Proteica , Proteínas Recombinantes/metabolismo , Regulon , Transdução de Sinais , Técnicas do Sistema de Duplo-Híbrido
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA